Mithra Pharmaceuticals SA
Mithra Pharmaceuticals SA, a leading biopharmaceutical company headquartered in Belgium, is renowned for its innovative approach to women's health. Founded in 1999, Mithra has established a strong presence in Europe and beyond, focusing on the development of contraceptive solutions and hormone therapies. The company’s flagship products, including the unique contraceptive pill Estelle and the innovative hormone replacement therapy, are designed to meet the specific needs of women, setting Mithra apart in a competitive market. With a commitment to research and development, Mithra has achieved significant milestones, positioning itself as a key player in the women's health sector. Recognised for its dedication to quality and innovation, Mithra Pharmaceuticals continues to expand its portfolio, striving to improve the lives of women globally through effective and safe healthcare solutions.
DitchCarbon Score
How does Mithra Pharmaceuticals SA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Mithra Pharmaceuticals SA's score of 28 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Mithra Pharmaceuticals SA's reported carbon emissions
Mithra Pharmaceuticals SA, headquartered in Belgium, currently does not have publicly available carbon emissions data or specific reduction targets. As of now, there are no documented initiatives or commitments related to carbon emissions reduction or climate pledges. In the absence of specific emissions figures, it is important to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and climate action. Mithra Pharmaceuticals may be expected to align with industry standards and practices in the future, but specific commitments or targets have not been disclosed at this time.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Mithra Pharmaceuticals SA is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
